Berkshire buys Teva, bites more Apple, feels IBM blues

By Kitco News / February 14, 2018 / www.kitco.com / Article Link

Feb 14 (Reuters) - Warren Buffett's Berkshire Hathaway Inc on Wednesday said it has taken a new stake in Teva Pharmaceutical Industries Ltd , significantly boosted its holdings of Apple Inc and has nearly shed a less successful investment in IBM Corp .

In a regulatory filing detailing its U.S.-listed stock holdings as of Dec. 31, Berkshire reported owning about 18.9 million of the American depositary receipts in Teva, one of the world's largest generic drug makers, worth about $358 million.

Teva's share price rose more than 10 percent after Berkshire reported its ownership stake.

Berkshire also reported a 23 percent increase since the end of September in its Apple stake, to about 165.3 million shares, and a 94.5 percent decline in its stake in International Business Machines Corp, to 2.05 million shares.


(Reporting by Jonathan Stempel in New York; Editing by Leslie Adler)

Disclaimer: The views expressed in this article are those of the author and may not reflect those of Kitco Metals Inc. The author has made every effort to ensure accuracy of information provided; however, neither Kitco Metals Inc. nor the author can guarantee such accuracy. This article is strictly for informational purposes only. It is not a solicitation to make any exchange in commodities, securities or other financial instruments. Kitco Metals Inc. and the author of this article do not accept culpability for losses and/ or damages arising from the use of this publication.

Recent News

Producing gold still up after metal reversal, juniors down

February 17, 2025 / www.canadianminingreport.com

Clear split between gold, silver stock ETFs and rest of sector in 2025

February 17, 2025 / www.canadianminingreport.com

Gold producers and juniors back to recent highs

February 10, 2025 / www.canadianminingreport.com

US tariff hikes shock market and drive retaliation

February 03, 2025 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok